Concepedia

Rink‐Jan Lohman

RL

Statistics

Publications

30

Citations

1.6K

H-Index

23

Active since

1998

Affiliations

The University of Queensland(Current)

Australian Research Council

Princess Alexandra Hospital

The University of Melbourne

ARC Centre of Excellence in Advanced Molecular Imaging

Rink‐Jan Lohman is an author at The University of Queensland specializing in pharmacology, medicine, and inflammation.

ORCID

Publications per year

1998–2023

30

Publications

30

Rational design and synthesis of an orally bioavailable peptide guided by NMR amide temperature coefficients

Conan K. Wang, Susan E. Northfield, Barbara Colless et al. · Proceedings of the National Academy of Sciences · 2014 · 172 citations · Full text

, , +17

Improving on Nature: Making a Cyclic Heptapeptide Orally Bioavailable

Daniel S. Nielsen, Huy N. Hoang, Rink‐Jan Lohman et al. · Angewandte Chemie International Edition · 2014 · 140 citations

, , +17

Diet‐induced obesity, adipose inflammation, and metabolic dysfunction correlating with PAR2 expression are attenuated by PAR2 antagonism

Junxian Lim, Abishek Iyer, Ligong Liu et al. · The FASEB Journal · 2013 · 110 citations

, , +17

Antagonism of Protease-Activated Receptor 2 Protects against Experimental Colitis

Rink‐Jan Lohman, Adam J. Cotterell, Jacky Y. Suen et al. · Journal of Pharmacology and Experimental Therapeutics · 2011 · 103 citations

, , +17

An antagonist of human protease activated receptor‐2 attenuates PAR2 signaling, macrophage activation, mast cell degranulation, and collagen‐induced arthritis in rats

Rink‐Jan Lohman, Adam J. Cotterell, Grant D. Barry et al. · The FASEB Journal · 2012 · 103 citations

, , +17

1–5 of 30